Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 175

1.

Viral testing of 18 consecutive cases of equine serum hepatitis: A prospective study (2014-2018).

Tomlinson JE, Kapoor A, Kumar A, Tennant BC, Laverack MA, Beard L, Delph K, Davis E, Schott Ii H, Lascola K, Holbrook TC, Johnson P, Taylor SD, McKenzie E, Carter-Arnold J, Setlakwe E, Fultz L, Brakenhoff J, Ruby R, Trivedi S, Van de Walle GR, Renshaw RW, Dubovi EJ, Divers TJ.

J Vet Intern Med. 2019 Jan;33(1):251-257. doi: 10.1111/jvim.15368. Epub 2018 Dec 5.

2.

Viral testing of 10 cases of Theiler's disease and 37 in-contact horses in the absence of equine biologic product administration: A prospective study (2014-2018).

Tomlinson JE, Tennant BC, Struzyna A, Mrad D, Browne N, Whelchel D, Johnson PJ, Jamieson C, Löhr CV, Bildfell R, McKenzie EC, Laverack M, Renshaw RW, Dubovi E, Kapoor A, Meirs RS, Belgrave R, Engiles J, Van de Walle GR, Divers TJ.

J Vet Intern Med. 2019 Jan;33(1):258-265. doi: 10.1111/jvim.15362. Epub 2018 Dec 6.

3.

Correction: miRNA independent hepacivirus variants suggest a strong evolutionary pressure to maintain miR-122 dependence.

Yu Y, Scheel TKH, Luna JM, Chung H, Nishiuchi E, Scull MA, Echeverría N, Ricardo-Lax I, Kapoor A, Lipkin WI, Divers TJ, Antczak DF, Tennant BC, Rice CM.

PLoS Pathog. 2018 Sep 17;14(9):e1007303. doi: 10.1371/journal.ppat.1007303. eCollection 2018 Sep.

4.

Mutation responsible for congenital photosensitivity and hyperbilirubinemia in Southdown sheep.

Posbergh CJ, Kalla SE, Sutter NB, Tennant BC, Huson HJ.

Am J Vet Res. 2018 May;79(5):538-545. doi: 10.2460/ajvr.79.5.538.

PMID:
29688779
5.

New Parvovirus Associated with Serum Hepatitis in Horses after Inoculation of Common Biological Product.

Divers TJ, Tennant BC, Kumar A, McDonough S, Cullen J, Bhuva N, Jain K, Chauhan LS, Scheel TKH, Lipkin WI, Laverack M, Trivedi S, Srinivasa S, Beard L, Rice CM, Burbelo PD, Renshaw RW, Dubovi E, Kapoor A.

Emerg Infect Dis. 2018 Feb;24(2):303-310. doi: 10.3201/eid2402.171031.

6.

miRNA independent hepacivirus variants suggest a strong evolutionary pressure to maintain miR-122 dependence.

Yu Y, Scheel TKH, Luna JM, Chung H, Nishiuchi E, Scull MA, Echeverría N, Ricardo-Lax I, Kapoor A, Lipkin WI, Divers TJ, Antczak DF, Tennant BC, Rice CM.

PLoS Pathog. 2017 Oct 30;13(10):e1006694. doi: 10.1371/journal.ppat.1006694. eCollection 2017 Oct. Erratum in: PLoS Pathog. 2018 Sep 17;14(9):e1007303.

7.

Equine Mesenchymal Stromal Cells from Different Sources Efficiently Differentiate into Hepatocyte-Like Cells.

Pennington MR, Curtis TM, Divers TJ, Wagner B, Ness SL, Tennant BC, Van de Walle GR.

Tissue Eng Part C Methods. 2016 Jun;22(6):596-607. doi: 10.1089/ten.TEC.2015.0403. Epub 2016 May 18.

PMID:
27113698
8.

AIC649 Induces a Bi-Phasic Treatment Response in the Woodchuck Model of Chronic Hepatitis B.

Paulsen D, Weber O, Ruebsamen-Schaeff H, Tennant BC, Menne S.

PLoS One. 2015 Dec 14;10(12):e0144383. doi: 10.1371/journal.pone.0144383. eCollection 2015.

9.

Characterization of nonprimate hepacivirus and construction of a functional molecular clone.

Scheel TK, Kapoor A, Nishiuchi E, Brock KV, Yu Y, Andrus L, Gu M, Renshaw RW, Dubovi EJ, McDonough SP, Van de Walle GR, Lipkin WI, Divers TJ, Tennant BC, Rice CM.

Proc Natl Acad Sci U S A. 2015 Feb 17;112(7):2192-7. doi: 10.1073/pnas.1500265112. Epub 2015 Feb 2.

10.

Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B.

Menne S, Tumas DB, Liu KH, Thampi L, AlDeghaither D, Baldwin BH, Bellezza CA, Cote PJ, Zheng J, Halcomb R, Fosdick A, Fletcher SP, Daffis S, Li L, Yue P, Wolfgang GH, Tennant BC.

J Hepatol. 2015 Jun;62(6):1237-45. doi: 10.1016/j.jhep.2014.12.026. Epub 2015 Jan 2.

11.

Capture of syncytin-Mar1, a fusogenic endogenous retroviral envelope gene involved in placentation in the Rodentia squirrel-related clade.

Redelsperger F, Cornelis G, Vernochet C, Tennant BC, Catzeflis F, Mulot B, Heidmann O, Heidmann T, Dupressoir A.

J Virol. 2014 Jul;88(14):7915-28. doi: 10.1128/JVI.00141-14. Epub 2014 Apr 30.

12.

Identification of a previously undescribed divergent virus from the Flaviviridae family in an outbreak of equine serum hepatitis.

Chandriani S, Skewes-Cox P, Zhong W, Ganem DE, Divers TJ, Van Blaricum AJ, Tennant BC, Kistler AL.

Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):E1407-15. doi: 10.1073/pnas.1219217110. Epub 2013 Mar 18.

13.

Electroporation enhances immunogenicity of a DNA vaccine expressing woodchuck hepatitis virus surface antigen in woodchucks.

Liu KH, Ascenzi MA, Bellezza CA, Bezuidenhout AJ, Cote PJ, Gonzalez-Aseguinolaza G, Hannaman D, Luxembourg A, Evans CF, Tennant BC, Menne S.

J Virol. 2011 May;85(10):4853-62. doi: 10.1128/JVI.02437-10. Epub 2011 Mar 9.

14.

Glucosidase inhibition enhances presentation of de-N-glycosylated hepatitis B virus epitopes by major histocompatibility complex class I in vitro and in woodchucks.

Norton PA, Menne S, Sinnathamby G, Betesh L, Cote PJ, Philip R, Mehta AS, Tennant BC, Block TM.

Hepatology. 2010 Oct;52(4):1242-50. doi: 10.1002/hep.23806.

15.

Semliki forest virus expressing interleukin-12 induces antiviral and antitumoral responses in woodchucks with chronic viral hepatitis and hepatocellular carcinoma.

Rodriguez-Madoz JR, Liu KH, Quetglas JI, Ruiz-Guillen M, Otano I, Crettaz J, Butler SD, Bellezza CA, Dykes NL, Tennant BC, Prieto J, González-Aseguinolaza G, Smerdou C, Menne S.

J Virol. 2009 Dec;83(23):12266-78. doi: 10.1128/JVI.01597-09. Epub 2009 Sep 9.

16.

Rapid immunity to vaccination with woodchuck hepatitis virus surface antigen using cationic liposome-DNA complexes as adjuvant.

Cote PJ, Butler SD, George AL, Fairman J, Gerin JL, Tennant BC, Menne S.

J Med Virol. 2009 Oct;81(10):1760-72. doi: 10.1002/jmv.21566.

PMID:
19697409
17.

Differential expression of the genes involved in amino acids and nitrogen metabolisms during liver regeneration of mice.

Yuan Y, Wu X, Ou Q, Gao J, Tennant BC, Han W, Yu Y.

Hepatol Res. 2009 Mar;39(3):301-12. doi: 10.1111/j.1872-034X.2008.00456.x. Epub 2008 Dec 2.

PMID:
19067752
18.

Correlation of virus and host response markers with circulating immune complexes during acute and chronic woodchuck hepatitis virus infection.

Glebe D, Lorenz H, Gerlich WH, Butler SD, Tochkov IA, Tennant BC, Cote P, Menne S.

J Virol. 2009 Feb;83(4):1579-91. doi: 10.1128/JVI.01934-08. Epub 2008 Dec 3.

19.

Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype.

Connolly E, Melegari M, Landgraf P, Tchaikovskaya T, Tennant BC, Slagle BL, Rogler LE, Zavolan M, Tuschl T, Rogler CE.

Am J Pathol. 2008 Sep;173(3):856-64. doi: 10.2353/ajpath.2008.080096. Epub 2008 Aug 7.

20.

Antiviral effects of lamivudine, emtricitabine, adefovir dipivoxil, and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection.

Menne S, Butler SD, George AL, Tochkov IA, Zhu Y, Xiong S, Gerin JL, Cote PJ, Tennant BC.

Antimicrob Agents Chemother. 2008 Oct;52(10):3617-32. doi: 10.1128/AAC.00654-08. Epub 2008 Aug 1.

21.

Immunogenicity in mice and rabbits of DNA vaccines expressing woodchuck hepatitis virus antigens.

Luxembourg A, Hannaman D, Wills K, Bernard R, Tennant BC, Menne S, Cote PJ.

Vaccine. 2008 Jul 29;26(32):4025-33. doi: 10.1016/j.vaccine.2008.05.021. Epub 2008 Jun 2.

PMID:
18556096
22.

The role of the woodchuck model in the treatment of hepatitis B virus infection.

Kulkarni K, Jacobson IM, Tennant BC.

Clin Liver Dis. 2007 Nov;11(4):707-25, vii. Review.

PMID:
17981226
23.

Natural iminosugar derivatives of 1-deoxynojirimycin inhibit glycosylation of hepatitis viral envelope proteins.

Jacob JR, Mansfield K, You JE, Tennant BC, Kim YH.

J Microbiol. 2007 Oct;45(5):431-40.

25.

Antiviral effect of orally administered (-)-beta-D-2-aminopurine dioxolane in woodchucks with chronic woodchuck hepatitis virus infection.

Menne S, Asif G, Narayanasamy J, Butler SD, George AL, Hurwitz SJ, Schinazi RF, Chu CK, Cote PJ, Gerin JL, Tennant BC.

Antimicrob Agents Chemother. 2007 Sep;51(9):3177-84. Epub 2007 Jul 2.

26.

Woodchuck dendritic cells generated from peripheral blood mononuclear cells and transduced with recombinant human adenovirus serotype 5 induce antigen-specific cellular immune responses.

Ochoa-Callejero L, Berraondo P, Crettaz J, Olagüe C, Vales A, Ruiz J, Prieto J, Tennant BC, Menne S, González-Aseguinolaza G.

J Med Virol. 2007 May;79(5):522-9.

PMID:
17385694
27.

Immunosuppression reactivates viral replication long after resolution of woodchuck hepatitis virus infection.

Menne S, Cote PJ, Butler SD, Toshkov IA, Gerin JL, Tennant BC.

Hepatology. 2007 Mar;45(3):614-22.

PMID:
17326155
28.

Quantitative evaluation of 2-deoxy-2[F-18]fluoro-D-glucose-positron emission tomography imaging on the woodchuck model of hepatocellular carcinoma with histological correlation.

Salem N, MacLennan GT, Kuang Y, Anderson PW, Schomisch SJ, Tochkov IA, Tennant BC, Lee Z.

Mol Imaging Biol. 2007 May-Jun;9(3):135-43.

PMID:
17308952
29.

Gene expression studies of hepatitis virus-induced woodchuck hepatocellular carcinoma in correlation with human results.

Wang F, Anderson PW, Salem N, Kuang Y, Tennant BC, Lee Z.

Int J Oncol. 2007 Jan;30(1):33-44.

PMID:
17143510
30.
31.
32.

Clevudine inhibits hepatitis delta virus viremia: a pilot study of chronically infected woodchucks.

Casey J, Cote PJ, Toshkov IA, Chu CK, Gerin JL, Hornbuckle WE, Tennant BC, Korba BE.

Antimicrob Agents Chemother. 2005 Oct;49(10):4396-9.

33.

Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection.

Menne S, Cote PJ, Korba BE, Butler SD, George AL, Tochkov IA, Delaney WE 4th, Xiong S, Gerin JL, Tennant BC.

Antimicrob Agents Chemother. 2005 Jul;49(7):2720-8.

34.

Korean medicinal plant extracts exhibit antiviral potency against viral hepatitis.

Jacob JR, Korba BE, You JE, Tennant BC, Kim YH.

J Altern Complement Med. 2004 Dec;10(6):1019-26.

PMID:
15673997
35.

Clevudine therapy with vaccine inhibits progression of chronic hepatitis and delays onset of hepatocellular carcinoma in chronic woodchuck hepatitis virus infection.

Korba BE, Cote PJ, Menne S, Toshkov I, Baldwin BH, Wells FV, Tennant BC, Gerin JL.

Antivir Ther. 2004 Dec;9(6):937-52.

PMID:
15651753
36.

Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans.

Block TM, Comunale MA, Lowman M, Steel LF, Romano PR, Fimmel C, Tennant BC, London WT, Evans AA, Blumberg BS, Dwek RA, Mattu TS, Mehta AS.

Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):779-84. Epub 2005 Jan 10.

37.

Hepatocellular carcinoma in the woodchuck model of hepatitis B virus infection.

Tennant BC, Toshkov IA, Peek SF, Jacob JR, Menne S, Hornbuckle WE, Schinazi RD, Korba BE, Cote PJ, Gerin JL.

Gastroenterology. 2004 Nov;127(5 Suppl 1):S283-93. Review.

PMID:
15508096
38.

Interferon-gamma-associated responses to woodchuck hepatitis virus infection in neonatal woodchucks and virus-infected hepatocytes.

Wang Y, Jacob JR, Menne S, Bellezza CA, Tennant BC, Gerin JL, Cote PJ.

J Viral Hepat. 2004 Sep;11(5):404-17.

PMID:
15357645
39.

GB virus B infection of the common marmoset (Callithrix jacchus) and associated liver pathology.

Jacob JR, Lin KC, Tennant BC, Mansfield KG.

J Gen Virol. 2004 Sep;85(Pt 9):2525-33.

PMID:
15302946
40.

Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model.

Jacob JR, Korba BE, Cote PJ, Toshkov I, Delaney WE 4th, Gerin JL, Tennant BC.

Antiviral Res. 2004 Aug;63(2):115-21.

PMID:
15302140
42.

Integration of woodchuck hepatitis and N-myc rearrangement determine size and histologic grade of hepatic tumors.

Jacob JR, Sterczer A, Toshkov IA, Yeager AE, Korba BE, Cote PJ, Buendia MA, Gerin JL, Tennant BC.

Hepatology. 2004 Apr;39(4):1008-16.

PMID:
15057905
43.

Kinetics of viremia and acute liver injury in relation to outcome of neonatal woodchuck hepatitis virus infection.

Wang Y, Menne S, Baldwin BH, Tennant BC, Gerin JL, Cote PJ.

J Med Virol. 2004 Mar;72(3):406-15.

PMID:
14748064
44.

Decreased oxidative DNA damage and accelerated cell turnover in woodchuck hepatitis virus infected liver.

O'Gorman MA, Sharma S, Groopman JD, Tennant BC, Tochkov IA, Schwarz KB.

Hepatol Res. 2003 Mar;25(3):254-262.

PMID:
12697246
45.

Role of type 1 versus type 2 immune responses in liver during the onset of chronic woodchuck hepatitis virus infection.

Wang Y, Menne S, Jacob JR, Tennant BC, Gerin JL, Cote PJ.

Hepatology. 2003 Apr;37(4):771-80.

PMID:
12668969
47.

Viral pharmacodynamic model for (-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine (emtricitabine) in chronically infected woodchucks.

Hurwitz SJ, Tennant BC, Korba BE, Liberman I, Gerin JL, Schinazi RF.

Antivir Chem Chemother. 2002 May;13(3):165-76.

PMID:
12448689
48.

Mutations in the conserved woodchuck hepatitis virus polymerase FLLA and YMDD regions conferring resistance to lamivudine.

Tatti KM, Korba BE, Stang HL, Peek S, Gerin JL, Tennant BC, Schinazi RF.

Antiviral Res. 2002 Jul;55(1):141-50.

PMID:
12076758
49.

Real-time polymerase chain reaction assays for leukocyte CD and cytokine mRNAs of the Eastern woodchuck (Marmota monax).

Menne S, Wang Y, Butler SD, Gerin JL, Cote PJ, Tennant BC.

Vet Immunol Immunopathol. 2002 Aug;87(1-2):97-105.

PMID:
12052347
50.

Lymphosarcoma in the laboratory woodchuck (Marmota monax).

Nagy T, McDonough SP, Erb HN, Smith CA, Baldwin BH, Tennant BC.

Comp Med. 2002 Apr;52(2):152-9.

PMID:
12022395

Supplemental Content

Loading ...
Support Center